Drugplain

Budesonide Inhalation Suspension .5 mg/2mL

Budesonide · INHALANT · Exelan Pharmaceuticals, Inc.

4 Recalls on Record
Plain English

Budesonide Inhalation Suspension is a inhalant containing budesonide at .5 mg/2mL, taken oral. Manufactured by Exelan Pharmaceuticals, Inc..

Key Facts

Brand Name
Budesonide Inhalation Suspension
Generic Name
Budesonide
NDC Code (Product)
76282-641
Manufacturer
Exelan Pharmaceuticals, Inc.
Strength
.5 mg/2mL
Dosage Form
INHALANT
Route
ORAL
Marketing Status
Application #
ANDA205710
Drug Class
Corticosteroid [EPC]
Marketing Start
04/17/2019

Recall History

4 Recalls on Record
Class II06/30/2025

Cipla USA, Inc.

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

OngoingVoluntary: Firm initiated
Class III01/11/2013

AstraZeneca LP

Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.

TerminatedVoluntary: Firm initiated
Class II09/15/2022

CIPLA

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class III01/11/2013

AstraZeneca LP

Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.

TerminatedVoluntary: Firm initiated

Frequently Asked Questions

What is Budesonide Inhalation Suspension used for?

Budesonide Inhalation Suspension contains Budesonide. It is a inhalant taken oral. Consult your doctor for specific uses.

Is Budesonide Inhalation Suspension a controlled substance?

Budesonide Inhalation Suspension is not classified as a controlled substance by the DEA.

What is the generic name for Budesonide Inhalation Suspension?

The generic name for Budesonide Inhalation Suspension is Budesonide. There are 11 other brand versions of Budesonide.

What is the NDC code for Budesonide Inhalation Suspension .5 mg/2mL?

The NDC (National Drug Code) for Budesonide Inhalation Suspension .5 mg/2mL is 76282-641, listed by Exelan Pharmaceuticals, Inc..